Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy

1. Choueiri, T.K.
2. Porta, C.
3. Suárez, C.
4. Hainsworth, J.
5. Voog, E.
6. Duran, I.
7. Reeves, J.
8. Czaykowski, P.
9. Castellano, D.
10. Chen, J.
11. Sedarati, F.
12. Powles, T.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ONCOLO/OYAC192 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus